UniProt ID | XPC_MOUSE | |
---|---|---|
UniProt AC | P51612 | |
Protein Name | DNA repair protein complementing XP-C cells homolog | |
Gene Name | Xpc | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 930 | |
Subcellular Localization | Nucleus. Cytoplasm. Omnipresent in the nucleus and consistently associates with and dissociates from DNA in the absence of DNA damage. Continuously shuttles between the cytoplasm and the nucleus, which is impeded by the presence of NER lesions (By si | |
Protein Description | Involved in global genome nucleotide excision repair (GG-NER) by acting as damage sensing and DNA-binding factor component of the XPC complex. Has only a low DNA repair activity by itself which is stimulated by Rad23b and Rad23a. Has a preference to bind DNA containing a short single-stranded segment but not to damaged oligonucleotides. This feature is proposed to be related to a dynamic sensor XPC can rapidly screen duplex DNA for non-hydrogen-bonded bases by forming a transient nucleoprotein intermediate complex which matures into a stable recognition complex through an intrinsic single-stranded DNA-binding activity.; The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, Xpa, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex. The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. The orientation of XPC complex binding appears to be crucial for inducing a productive NER. XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair. In vitro, the Xpc:Rad23b dimer is sufficient to initiate NER; it preferentially binds to cisplatin and UV-damaged double-stranded DNA and also binds to a variety of chemically and structurally diverse DNA adducts. XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a preference for the 5' side. Xpc:Rad23b induces a bend in DNA upon binding. Xpc:Rad23b stimulates the activity of DNA glycosylases Tdg and Smug1 (By similarity).. | |
Protein Sequence | MAPKRTADGRRRKRGQKTEDNKVARHEESVADDFEDEKQKPRRKSSFPKVSQGKRKRGCSDPGDPTNGAAKKKVAKATAKSKNLKVLKEEALSDGDDFRDSPADCKKAKKHPKSKVVDQGTDEDDSEDDWEEVEELTEPVLDMGENSATSPSDMPVKAVEIEIETPQQAKERERSEKIKMEFETYLRRMMKRFNKEVQENMHKVHLLCLLASGFYRNSICRQPDLLAIGLSIIPIRFTKVPLQDRDAYYLSNLVKWFIGTFTVNADLSASEQDDLQTTLERRIAIYSARDNEELVHIFLLILRALQLLTRLVLSLQPIPLKSAVTKGRKSSKETSVEGPGGSSELSSNSPESHNKPTTSRRIKEEETLSEGRGKATARGKRGTGTAGSRQRRKPSCSEGEEAEQKVQGRPHARKRRVAAKVSYKEESESDGAGSGSDFEPSSGEGQHSSDEDCEPGPRKQKRASAPQRTKAGSKSASKTQRGSQCEPSSFPEASSSSSGCKRGKKVSSGAEEMADRKPAGVDQWLEVYCEPQAKWVCVDCVHGVVGQPVACYKYATKPMTYVVGIDSDGWVRDVTQRYDPAWMTATRKCRVDAEWWAETLRPYRSLLTEREKKEDQEFQAKHLDQPLPTSISTYKNHPLYALKRHLLKFQAIYPETAAVLGYCRGEAVYSRDCVHTLHSRDTWLKQARVVRLGEVPYKMVKGFSNRARKARLSEPQLHDHNDLGLYGHWQTEEYQPPIAVDGKVPRNEFGNVYLFLPSMMPVGCVQMTLPNLNRVARKLGIDCVQAITGFDFHGGYCHPVTDGYIVCEEFRDVLLAAWENEQAIIEKKEKEKKEKRALGNWKLLVRGLLIRERLKLRYGAKSEAAAPHAAGGGLSSDEEEGTSSQAEAARVLAASWPQNREDPEQKSEYTKMTRKRRAAEASHLFPFEKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
60 | Phosphorylation | GKRKRGCSDPGDPTN CCCCCCCCCCCCCCC | 50.06 | 22802335 | |
93 | Phosphorylation | VLKEEALSDGDDFRD HHHHHHHCCCCCCCC | 46.74 | 25521595 | |
101 | Phosphorylation | DGDDFRDSPADCKKA CCCCCCCCHHHHHHH | 20.10 | 25619855 | |
126 | Phosphorylation | QGTDEDDSEDDWEEV CCCCCCCCCCCHHHH | 56.07 | - | |
165 | Phosphorylation | AVEIEIETPQQAKER EEEEEECCHHHHHHH | 31.87 | 25266776 | |
170 | Ubiquitination | IETPQQAKERERSEK ECCHHHHHHHHHHHH | 53.63 | 22790023 | |
195 | Ubiquitination | RMMKRFNKEVQENMH HHHHHHHHHHHHHHH | 57.46 | 27667366 | |
239 | Ubiquitination | IIPIRFTKVPLQDRD EEEEEEEECCCCCCH | 38.86 | 27667366 | |
330 | Phosphorylation | AVTKGRKSSKETSVE HHHCCCCCCCCCCCC | 45.33 | 21082442 | |
331 | Phosphorylation | VTKGRKSSKETSVEG HHCCCCCCCCCCCCC | 37.23 | 21082442 | |
334 | Phosphorylation | GRKSSKETSVEGPGG CCCCCCCCCCCCCCC | 41.63 | 25619855 | |
335 | Phosphorylation | RKSSKETSVEGPGGS CCCCCCCCCCCCCCC | 21.18 | 25619855 | |
342 | Phosphorylation | SVEGPGGSSELSSNS CCCCCCCCCCCCCCC | 26.93 | 25619855 | |
343 | Phosphorylation | VEGPGGSSELSSNSP CCCCCCCCCCCCCCC | 45.92 | 25619855 | |
346 | Phosphorylation | PGGSSELSSNSPESH CCCCCCCCCCCCCCC | 24.34 | 27742792 | |
347 | Phosphorylation | GGSSELSSNSPESHN CCCCCCCCCCCCCCC | 54.69 | 27742792 | |
349 | Phosphorylation | SSELSSNSPESHNKP CCCCCCCCCCCCCCC | 31.80 | 27087446 | |
352 | Phosphorylation | LSSNSPESHNKPTTS CCCCCCCCCCCCCCC | 35.43 | 25619855 | |
357 | Phosphorylation | PESHNKPTTSRRIKE CCCCCCCCCCHHHCH | 38.73 | 25619855 | |
358 | Phosphorylation | ESHNKPTTSRRIKEE CCCCCCCCCHHHCHH | 28.85 | 25619855 | |
359 | Phosphorylation | SHNKPTTSRRIKEEE CCCCCCCCHHHCHHH | 23.26 | 25619855 | |
367 | Phosphorylation | RRIKEEETLSEGRGK HHHCHHHHHCCCCCC | 38.57 | 29472430 | |
369 | Phosphorylation | IKEEETLSEGRGKAT HCHHHHHCCCCCCCC | 45.48 | 26824392 | |
395 | Phosphorylation | SRQRRKPSCSEGEEA CCCCCCCCCCCCHHH | 33.05 | 25521595 | |
397 | Phosphorylation | QRRKPSCSEGEEAEQ CCCCCCCCCCHHHHH | 53.63 | 25521595 | |
643 | Ubiquitination | NHPLYALKRHLLKFQ CCHHHHHHHHHHHHH | 29.60 | 22790023 | |
685 | Ubiquitination | HSRDTWLKQARVVRL HCCCCHHHHCEEEEE | 33.21 | 22790023 | |
743 | Ubiquitination | PPIAVDGKVPRNEFG CCEEECCEECCCCCC | 44.60 | 22790023 | |
862 | Phosphorylation | KLRYGAKSEAAAPHA HHHHCCCCCCCCCCC | 31.75 | 25619855 | |
875 | Phosphorylation | HAAGGGLSSDEEEGT CCCCCCCCCCCCCCC | 38.73 | 25521595 | |
876 | Phosphorylation | AAGGGLSSDEEEGTS CCCCCCCCCCCCCCC | 54.83 | 25521595 | |
882 | Phosphorylation | SSDEEEGTSSQAEAA CCCCCCCCCHHHHHH | 28.60 | 24723360 | |
883 | Phosphorylation | SDEEEGTSSQAEAAR CCCCCCCCHHHHHHH | 31.17 | 25619855 | |
884 | Phosphorylation | DEEEGTSSQAEAARV CCCCCCCHHHHHHHH | 32.99 | 25619855 | |
895 | Phosphorylation | AARVLAASWPQNRED HHHHHHHHCCCCCCC | 33.41 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of XPC_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of XPC_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of XPC_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-93; SER-395 AND SER-397,AND MASS SPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-875 AND SER-876, ANDMASS SPECTROMETRY. |